comparemela.com

Page 2 - Project Lucy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insider Cannabis Newsletter: May 21

Executive Moves Martha Stewart would become an official strategic advisor. Erik Knutson as CEO of cannabis beverage company Keef Brands. Tharp was previously president and COO, and Knutson will remain on the board.  Deals, launches, and IPOs Aurora Cannabis filed for a $300 million stock sale on Thursday. The filing mentions a possibility of a US acquisition, MarketWatch reports.  Cannabis SPAC Mercer Park Brand Acquisition Corp. said on Monday that it has upsized a previously announced equity investment to include $50 million from TPCO Holdings Corp. In total, Mercer Park has raised $135 million for the transaction.  HEXO Corpannounced on Monday it would acquire 48North Cannabis Corp in a C$50 million stock deal. 

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial News provided by Share this article MindMed Finalizes Clinical Development Approach for LSD Targeting Generalized Anxiety Disorder as Initial Indication NEW YORK, May 17, 2021 /PRNewswire/  MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announces receipt of Type C Meeting Responses from FDA leading to the finalization of the Company s clinical development approach for Project Lucy by selecting Generalized Anxiety Disorder as an initial indication. MindMed is on target to formally submit its Investigational New Drug (IND) application for Project Lucy in Q3 2021 and expects to launch its Phase 2b clinical trial shortly thereafter in Q4 2021.

Mind Medicine (MNMD) Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

Mind Medicine (MNMD) Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

The Buzz Show: MindMed (NASDAQ: MNMD) Receives FDA Type C for Project Lucy Phase 2b Clinical Trial | Financial Buzz The Buzz Show: MindMed (NASDAQ: MNMD) Receives FDA Type C for Project Lucy Phase 2b Clinical Trial

The Buzz Show: MindMed (NASDAQ: MNMD) Receives FDA Type C for Project Lucy Phase 2b Clinical Trial | Financial Buzz The Buzz Show: MindMed (NASDAQ: MNMD) Receives FDA Type C for Project Lucy Phase 2b Clinical Trial
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.